Improving Drug Development: Molecular Devices and Cellesce Aim to Advance the Use of Organoids
Molecular Devices, a life science tools company, has long been associated with its plate reader, imaging technology and software. Now, the company is making significant investments in organoid technologies, which it views as the future of drug discovery and development. These investments include the acquisition of organoid provider Cellesce, a developer and manufacturer of patient-derived […]